Suppr超能文献

鉴定 PPT1 为肝癌中具有预后价值的溶酶体核心基因。

Identification of PPT1 as a lysosomal core gene with prognostic value in hepatocellular carcinoma.

机构信息

The First Affiliated Hospital of Dalian Medical University, Dalian, China.

Dalian Medical University, Dalian, China.

出版信息

Biosci Rep. 2023 May 31;43(5). doi: 10.1042/BSR20230067.

Abstract

Hepatocellular carcinoma (HCC) is the most frequent cancer worldwide with a poor prognosis. Unfortunately, there are few reports on effective biomarkers for HCC, identification of novel cancer targets is urgently needed. Lysosomes are central organelles for degradation and recycling processes in cells, and how lysosome-related genes are involved in the progression of hepatocellular carcinoma remains unclear. The aim of the present study was to identify key lysosome-related genes affecting HCC. In the present study, lysosome-related genes involved in HCC progression were screened based on the TCGA (The Cancer Genome Atlas) dataset. Differentially expressed genes (DEGs) were screened, and core lysosomal genes were obtained in combination with prognostic analysis and protein interaction networks. Two genes were associated with survival, and their prognostic value was validated by prognostic profiling. After mRNA expression validation and IHC, the palmitoyl protein thioesterase 1 (PPT1) gene was identified as an important lysosomal-related gene. We demonstrated that PPT1 promotes the proliferation of HCC cells in vitro. In addition, quantitative proteomics and bioinformatics analysis confirmed that PPT1 acts by affecting the metabolism, localization, and function of various macromolecular proteins. The present study reveals that PPT1 could be a promising therapeutic target for the treatment of HCC. These findings provided new insights into HCC and identified candidate gene prognosis signatures for HCC.

摘要

肝细胞癌 (HCC) 是全球最常见的癌症,预后较差。不幸的是,目前关于 HCC 的有效生物标志物的报道很少,因此迫切需要鉴定新的癌症靶点。溶酶体是细胞内降解和回收过程的核心细胞器,溶酶体相关基因如何参与肝癌的进展仍不清楚。本研究旨在鉴定影响 HCC 的关键溶酶体相关基因。本研究基于 TCGA(癌症基因组图谱)数据集筛选参与 HCC 进展的溶酶体相关基因。进行差异表达基因 (DEG) 筛选,并结合预后分析和蛋白质相互作用网络获得核心溶酶体基因。有两个基因与生存相关,并通过预后分析验证了其预后价值。经过 mRNA 表达验证和免疫组化分析,鉴定出棕榈酰蛋白硫酯酶 1 (PPT1) 基因为重要的溶酶体相关基因。我们证明 PPT1 在体外促进 HCC 细胞的增殖。此外,定量蛋白质组学和生物信息学分析证实 PPT1 通过影响各种大分子蛋白的代谢、定位和功能来发挥作用。本研究揭示了 PPT1 可能成为治疗 HCC 的有前途的治疗靶点。这些发现为 HCC 提供了新的见解,并鉴定出 HCC 的候选基因预后标志物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d48/10196150/cda9c8432c3f/bsr-43-bsr20230067-g1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验